Financings Of The Fortnight Sees A Hot Market For Health Care IPOs ... In China
This article was originally published in The Pink Sheet Daily
Plus news on recent financings by Array Biopharma, Delenex Therapeutics, Naurex and Fate Therapeutics.
You may also be interested in...
Switzerland's Shield Therapeutics Raises $12M To Conduct Phase III Trials On Oral Iron Deficiency Product
Oral iron deficiency therapy to advance into Phase III this year on the back of $12 million fund raising for Swiss minnow, Shield Therapeutics.
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.